Prevention of glucocorticoid-induced osteoporosis: Experience in a managed care setting

Archives of Internal Medicine

Volumn 161, Issue 10, 2001, Pages 1322-1327

  Yood, Robert A ^a,b   Harrold, Leslie R ^b   Fish, Leslie ^a   Cernieux, Jackie ^b   Emani, Srinivas ^a   Conboy, Elisabeth ^a   Gurwitz, Jerry H ^b  

^a Fallon Clinic   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; ESTROGEN; GLUCOCORTICOID; PREDNISONE; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; COHORT ANALYSIS; CORTICOSTEROID THERAPY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL SPECIALIST; OSTEOPOROSIS; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; SEX DIFFERENCE; STATISTICAL ANALYSIS; WEIGHT BEARING;

EID: 0034924611     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.10.1322     Document Type: Article

References (46)

1. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis: A randomized, controlled study
2. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women
3. Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis: Effects of low-dose corticosteroids
4. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial
5. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the Oslo County rheumatoid arthritis register
6. Use of oral corticosteroids and risk of fractures
7. Efficiency of quantitative ultrasound measurements as compared with dual energy x-ray absorptiometry in the assessment of corticosteroid-induced bone impairment
8. Altered trabecular architecture induced by corticosteroids: A bone histomorphometric study
9. Rheumatoid arthritis, corticosteroid therapy and hip fracture
10. Steroid-induced fractures and bone loss in patients with asthma
11. Predictors of fractures in early rheumatoid arthritis
12. Fractures in rheumatoid arthritis an evaluation of associated risk factors
13. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
14. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
15. The role of vitamin D in corticosteroid-induced osteoporosis: A meta-analytic approach
16. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss
17. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids
18. Testosterone therapy in glucocorticoid-treated men
19. Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy?
20. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica
21. Salmon calcitonin nasal spray and the prevention of corticosteroid-induced osteoporosis
22. New developments in the pathogenesis and treatment of steroid-induced osteoporosis
23. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
24. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss
25. Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment: A double blind, randomised placebo controlled study
26. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment
27. A meta-analysis on the use of bisphosphonates in corticosteroid induced osteoporosis
28. Risedronate therapy prevents corticosteroid-induced bone loss: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
29. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis: Results of a randomized controlled clinical trial
30. Steroid induced osteoporosis: An opportunity for prevention?
31. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross-sectional study
32. Prevention of glucocorticoid-induced osteoporosis: Provider practice at an urban county hospital
33. Prevention of corticosteroid-induced osteoporosis: Results of a patient survey
34. Prevention of glucocorticoid induced osteoporosis
35. A UK consensus group on management of glucocorticoid-induced osteoporosis: An update
36. Health maintenance in clinical practice: Strategies and barriers
37. Why do patients with atrial fibrillation not receive warfarin?
38. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty
39. Implications of generalists' slow adoption of zidovudine in clinical practice
40. Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians
41. Prescribing for seniors: Neither too much nor too little
42. The treatment of unrelated disorders in patients with chronic medical diseases
43. Discrepancies in the use of medications: Their extent and predictors in an outpatient practice
44. Medication review and documentation in physician office practice
45. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: A randomized controlled trial
46. Improving preventive care by prompting physicians